PR Newswire
16 Nov 2023, 09:45 GMT+10
SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- On 10 November 2023, the sixth China International Import Expo (CIIE) successfully concluded at the National Exhibition and Convention Center in Shanghai. This year, Jiahui provided healthcare support for the China International Import Expo (CIIE) as the designated medical provider for the sixth consecutive year. Over and above this, Jiahui Health also participated in the Expo as part of the trade delegation and established in-depth strategic collaborations with several global leading medical brands, one of the most notable of which is IASO Biotechnology.
Jiahui Health and IASO BioTherapeutics announced the strategic collaboration to jointly build a BCMA-targeted CAR-T Equecabtagene Autoleucel Injection treatment center.
Jiahui Health and IASO Biotechnology announced a deepening of their strategic collaboration to jointly build a BCMA-targeted CAR-T Equecabtagene Autoleucel Injection treatment center and further promote the long-term sustainable development of the CAR-T international treatment platform. Jiahui will continue to focus on internationally advanced treatment concepts, medication, and technologies for the benefit of local and foreign patients in China.
Jiahui International Cancer Center has established an international CAR-T treatment team and has successfully carried out treatments in collaboration with various companies, including IASO Biotechnology and Fosun Kite. Jiahui's CAR-T multidisciplinary treatment team, led by Dr. Vicky LEE, Director of the Jiahui International Cancer Center and Chief of Medical Oncology at Jiahui International Cancer Center, has conducted a series of studies in the clinical practice of novel technologies and has successfully developed various international treatments.
In September, the first foreign lymphoma patient in China was treated with Akilenza Injection CAR-T and was successfully discharged from Jiahui International Hospital three weeks after completing the infusion. In addition to the CAR-T patients who have been successfully discharged from the hospital after treatment, there are also a number of hematology-oncology patients from abroad who have chosen to undergo CAR-T treatment at Jiahui International Cancer Center. This includes both foreigners who have been living in China for an extended period as well as myeloma patients currently living abroad who are in urgent need of CAR-T treatment. Jiahui has been their choice for treatment based on the international standard hardware and software available, the comprehensive treatment capabilities, the cross-cultural and multilingual setting, the comfortable environment, and the international standard cost-effective clinical application of CAR-T therapy provided.
Jiahui International Cancer Center (JICC), affiliated with Shanghai Jiahui International Hospital in Shanghai, China, has a close strategic collaboration with Massachusetts General Hospital (MGH) and its cancer center. Jiahui International Cancer Center represents the cutting edge of international oncology, by integrating both internal and external medical and social resources to provide comprehensive diagnosis and treatment, fully aligned with the concept of holistic care.
Get a daily dose of Asia Bulletin news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Asia Bulletin.
More InformationThe death toll in Friday's massive earthquake in Myanmar has risen to nearly 700, and is expected to rise significantly. At least another...
WASHINGTON, D.C.: In response to soaring egg prices and supply shortages driven by a devastating bird flu outbreak, the United States...
WASHINGTON, D.C.: U.S. President Donald Trump vowed this week that more countries will be added to the Abraham Accords, the series...
TOKYO, Japan: This week, Japan's cherry blossom season officially began as experts confirmed the first blooms in Tokyo. A specialist...
CAPE TOWN, South Africa: The U.S. Embassy in South Africa said it received a list of over 67,000 people interested in refugee status...
RALEIGH, North Carolina: North Carolina's highest court has ruled that a mother and her teenage son can pursue a lawsuit over a COVID-19...
BENGALURU, India: A major regulatory breakthrough in India could mark a turning point for Starlink, Elon Musk's satellite internet...
NEW YORK, New York - Renewed fears about inflation, and U.S. Donald Trump's trade policies say American markets take a deep dive Friday....
NEW YORK CITY, New York: Segway is recalling about 220,000 scooters in the U.S. because of a safety issue that can cause riders to...
BEIJING, China: As global tech firms navigate rising geopolitical tensions, China has extended a warm signal to Apple, one of its most...
NEW YORK, New York - Shares in automakers fell sharply Thursday after U.S.President Donald Trump imposed a 25 percent tariff on all...
WASHINGTON, D.C.: Federal safety regulators have launched a new investigation into Ford's best-selling F-150 pickup trucks after receiving...